U.S. Diabetes Prevention Program Might Avert 885... (program would include 16 intensive core ...)

U.S. Diabetes Prevention Program Might Avert 885,000 Cases

Date:1/12/2012

program would include 16 intensive core sessions offered over five months to help people lose weight and to adopt other healthy lifestyle habits. The researchers estimated a weight loss of about nine pounds.

The first sessions would be followed by six monthly sessions to help reinforce and sustain the new lifestyle changes. During the second year, people would be offered eight maintenance sessions.

During the first- and second-year sessions, the training would be offered by trained lifestyle coaches. Next, follow-up sessions would be conducted by a health care provider once or twice a year, according to the study.

Realizing that not everyone would maintain a weight loss or a new exercise regimen, the authors assumed that there would be a 40 percent risk reduction in diabetes for the first two years for people between 18 and 64. They also assumed that after the first two years, there would be a decrease in the risk reduction of about 10 percent per year.

Zhuo and colleagues also assumed that older people might be more likely to sustain healthy changes and figured a 50 percent reduction in diabetes risk for the first two years and a 15 percent decline in risk reduction for each subsequent year in people between 65 and 84 years old.

The cost of this intervention would be about $300 per person for the first year, $150 for the second and about $50 a year thereafter, according to the report. The authors estimated it would take about 14 years to recoup this investment. But, over 25 years, it would save nearly $6 billion in health care costs.

Zhuo said the biggest barrier to implementing such a program would be funding. But, he said, policies offering incentives to private insurers for providing diabetes-prevention reimbursement might help get more insurers to consider making the investment.

Some insurers are onboard with the concept of prevention programs. In another article in the same issue of the journal, Deneen Vojta, c
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Novel Stem Cell Treatment May Hold Promise for Type 1 Diabetes
2. Why coffee drinking reduces the risk of Type 2 diabetes
3. Certain Diabetes Drugs Might Aid Weight Loss
4. Diabetes Takes a Toll on Lifetime Earnings: Study
5. Diabetes study shines spotlight on lifestyle interventions
6. Statins May Boost Diabetes Risk in Older Women
7. For those with diabetes, controlling blood pressure is crucial, but not urgent
8. Weight Loss Surgery May Help Diabetes
9. Diabetes Care Thwarted by Unstable Health Insurance: Study
10. Heart Failure, Diabetes Might Be Linked by Protein
11. Kaiser Permanente study finds continuous health coverage essential for patients managing diabetes

Post Your Comments:

Related Image:

U.S. Diabetes Prevention Program Might Avert 885,000 Cases

(Date:5/21/2013)... CA (PRWEB) May 21, 2013 DISCcert ... materials showing how to use 17 DISC applications at ... is a natural progression. , The July 25 & ... the top 17 ways of applying DISC. The time-tested, ... certified graduates. The user-friendly DISC training materials ...

(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... to protecting the rights of victims injured by defective ... Journal of Bone & Joint Surgery on May 15, ... can be used to identify complications that occur in ... any symptoms of failure. ( http://www.jbjs.org/article.aspx?articleid=1684770 ) ...

(Date:5/21/2013)... The Orsiro stent, which is a novel stent ... non-inferiority to the Xience Prime everolimus-eluting stent for ... loss at nine months in the results of ... , The BIOFLOW-II substudy used intravascular ultrasound (IVUS) ... neointimal hyperplasia and stent apposition at nine months ...

(Date:5/21/2013)... Hillsboro, OR (PRWEB) May 21, 2013 ... curing systems at the 20th Annual IMI European ... As a proven market leader, Phoseon continues to invest ... while accelerating the adoption of UV LED curing in ... of product families on the market offering both air ...

(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...

Breaking Medicine News(10 mins):Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3 Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2 Health News:Researchers find genetic risk factor for pulmonary fibrosis 2

[0] DISCcert Offers 17 Applications in Coming DISC Certification [0] Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants [0] Biodegradable stent proves non-inferior to drug-eluting stent [0] Phoseon Technology Presents the Leading UV LED Curing Solutions at IMI European Ink Jet Conference [0] Researchers find genetic risk factor for pulmonary fibrosis

... The Lancet Supports Cardio-Protective Potential of Aleglitazar - , ... will start Phase III clinical investigations for aleglitazar, its innovative ... morbidity and mortality in high risk patients with type 2 ... II SYNCHRONY study published today in The Lancet(1) ...

... , Customizable Survival Kit Offers One Stop for ... Local Healthcare Market Drivers and Health Plan Trends ... a leading provider of managed care market intelligence, ... shifts in membership at the state level than ...

... the company that will become public from the planned ... today filed a second amendment to its Form 10 ... that includes information about its post-spin board of directors ... under a consent decree for its Alaris(R) infusion products. ...

... United Spinal Association ( www.UnitedSpinal.org ) presents the ... ) , the region,s premiere lifestyle-enhancing Expo designed to ... aging Americans. , , The Independence Expo will ... at the Suffolk Community College Sports & Exhibition Complex in ...

... PSI-7851 was generally safe and well tolerated in Phase 1a ... results from single ascending and multiple ascending dose trials are ... June 9 Pharmasset, Inc. (Nasdaq: VRUS ) ... study and begun dosing in a multiple ascending dose trial ...

... ... its Multilayer Aneurysm Repair System (MARS) has received CE Mark approval for treating patients ... ... announced today that it has received CE Mark approval for the commercial sale of ...

Cached Medicine News:Health News:Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 2 Health News:Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 3 Health News:Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 4 Health News:Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 5 Health News:Commercial Pharmacy Benefit Enrollment Experiencing Greater Shifts in Florida than Commercial Medical Benefit Enrollment 2 Health News:CareFusion Announces Board of Directors, Progress on Alaris Consent Decree 2 Health News:CareFusion Announces Board of Directors, Progress on Alaris Consent Decree 3 Health News:CareFusion Announces Board of Directors, Progress on Alaris Consent Decree 4 Health News:United Spinal Association Presents The 2009 Independence Expo: Improving Life for the Disabled and the Aging 2 Health News:Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients 2 Health News:Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients 3 Health News:Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients 4 Health News:Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms 2

Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack Commercial Pharmacy Benefit Enrollment Experiencing Greater Shifts in Florida than Commercial Medical Benefit Enrollment CareFusion Announces Board of Directors, Progress on Alaris Consent Decree United Spinal Association Presents The 2009 Independence Expo: Improving Life for the Disabled and the Aging Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms

(Date:5/21/2013)... 2013 Lakeland Industries, Inc. (NASDAQ: ... protective clothing for industry, municipalities, healthcare and first ... today announced that the Company accepted a commitment ... Facility subject to certain terms and conditions and ... no assurances can be given that this transaction ...

(Date:5/21/2013)... 21, 2013 Tom Daulton, CEO of Mammotome, a division ... Year by the Cincinnati chapter of ... by another local top executive who is also a breast ... Ethicon Endo-Surgery in March of 2010. Daulton will be presented ... presented by Huntington Bank, on May 22. The ...

(Date:5/21/2013)... Kepner-Tregoe (KT), the global capability development ... Chris Geraghty has been ... than 20 years serving the industrial sector, holding ... succeeds Ray Baxter , who ... the Board and CEO. (Logo: ...

[0] Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results [0] Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year [0] Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer

... 14, 2011 /PRNewswire / -- Nephros, Inc. (OTC Bulletin Board: ... three months ended September 30, 2011. Recent ... associated with Rights Offering to be exercised; Received initial ... Hemodiafiltration System in U.S. Financial ...

... 14, 2011 Landauer, Inc. (NYSE: LDR ... radiation monitoring and the leading domestic provider of outsourced ... all of the outstanding equity interests of IZI Medical ... a purchase price of approximately $93 million. IZI Medical ...

Cached Medicine Technology:Nephros Reports Third Quarter 2011 Financial Results 2 Nephros Reports Third Quarter 2011 Financial Results 3 Nephros Reports Third Quarter 2011 Financial Results 4 Nephros Reports Third Quarter 2011 Financial Results 5 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 2 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 3 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 4 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 5 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 6

Nephros Reports Third Quarter 2011 Financial Results Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • Not available with casters • With Tubular Base....

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....

Medicine Products:

4V63 4V61-R 4V42-R 4V58-R